Amicrobe
Carlsbad, US
Biotech
Founders & leadership
AC
Albert CarnesaleDirector
MB
Michael BevilacquaExecutive Officer, Director
MF
Michael FleschExecutive Officer, Director
MB
Martin BurnsDirector
DH
Daniel HuangExecutive Officer
Reported raises · per SEC filings
Form D private placements▶$16.7MraisedApr 2024 · 32 investors · BiotechnologyRule 506(b)
▶$16.7MraisedApr 2024 · 32 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Albert CarnesaleDirector
- Michael BevilacquaExecutive Officer, Director
- Michael FleschExecutive Officer, Director
- Martin BurnsDirector
- Daniel HuangExecutive Officer
- Offering amount
- $24.6M
- Amount sold
- $16.7M
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedApr 2024 · 51 investors · BiotechnologyRule 506(b)
▶$5MraisedApr 2024 · 51 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Martin BurnsDirector
- Albert CarnesaleDirector
- Daniel HuangExecutive Officer
- Michael BevilacquaExecutive Officer, Director
- Michael FleschExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Sep 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.